Product Review

Optivite PMT is the first multivitamin - multimineral supplement formulated for use by women with Premenstrual tension syndromes (PMTS). Available to PMTS sufferers over the past 20 years, Optivite underwent several clinical studies published in peer-reviewed medical journals: 3 open trials and 2 double blind placebo-controlled studies. A 50% reduction of PMTS complaints has been observed in those studies following 1 to 3 months on this supplement. When 313 PMTS sufferers were followed for up to 5 years on this program, an interesting observation was that the number of tablets of Optivite required to maintain the improvement in PMTS complaints decreased over time: 5.2 0.36 tablets between 2 and 6 months: 4.8 + 0.6 tablets between 7 and 12 months: 4.3 + 0.48 tablets between 13 and 24 months and 3.2 + 0.34 tablets over 24 months. With over 100,000 women on this program during the first 5 years of availability of Optivite, not a single documented case of Vitamin A toxicity and peripheral neuropathy due to Vitamin B-6 has been reported. Optivite is recommended as part of a total dietary program to obtain best results.